Publications:

Flavopiridol synergizes with sorafenib to induce cytotoxicity and potentiate antitumorigenic activity in EGFR/HER-2 and mutant RAS/RAF breast cancer model systems.

Neoplasia (New York, N.Y.)

Nagaria, Teddy S TS; Williams, Julia L JL; Leduc, Charles C; Squire, Jeremy A JA; Greer, Peter A PA; Sangrar, Waheed W

Publication Date: 2013-08

Variant appearance in text: PTEN: A309A

PubMed Link: 23908594

Variant Present in the following documents:

• Main text

View BVdb publication page